PJAK2 (1001–1013)

This cell-permeable phosphopeptide acts as a SOCS1/3 antagonist, blocking their negative regulation of the JAK/STAT pathway. It is a valuable research tool for enhancing cytokine signaling in studies of antiviral immunity, immune cell activation, and inflammatory disease models, both in vitro and in vivo.